AwesomeCapital
Search This Blog
Monday, March 2, 2020
Intra-Cellular Therapies EPS beats by $0.06
Intra-Cellular Therapies (NASDAQ:
ITCI
): Q4 GAAP EPS of -$0.74
beats by $0.06
.
Revenue of $0.06M
Press Release
https://seekingalpha.com/news/3547345-intra-cellular-therapies-eps-beats-0_06
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.